Clinical Trial Update: Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE) [Phase 3]

View source ↗

Summary

Phase 3 PREPARE trial in breast cancer evaluating preoperative combinations of epirubicin, paclitaxel, and darbepoetin alfa (Aranesp) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARANESP (DARBEPOETIN ALFA)
• Epirubicin (epirubicin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: GBG Forschungs GmbH | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED